Novus Therapeutics Inc (NVUS) Stock Overview
NASDAQ:NVUS -
NVUS Key Statistics, Chart & Performance
The current stock price of NVUS is 14.6 null. In the past month the price decreased by -35.54%. In the past year, price decreased by -9.36%.
About NVUS
Company Profile
Novus Therapeutics, Inc. is a pharmaceutical company. It focused on the acquisition, development and commercialization of ear, nose and throat products. The company's platform consists of OP-01 Foam Platform and OP-02 Surfactant Program. Novus Therapeutics, Inc., formerly known as Tokai Pharmaceuticals Inc., is based in Irvine, United States.
Company Info
Novus Therapeutics Inc
19900 MACARTHUR BOULEVARD SUITE 550
IRVINE CA 92612
CEO: Gregory J. Flesher
Phone: 949-238-8090
Novus Therapeutics Inc / NVUS FAQ
What is the stock price of Novus Therapeutics Inc today?
The current stock price of NVUS is 14.6 null. The price decreased by -5.19% in the last trading session.
What is the ticker symbol for Novus Therapeutics Inc stock?
The exchange symbol of Novus Therapeutics Inc is NVUS and it is listed on the Nasdaq exchange.
On which exchange is NVUS stock listed?
NVUS stock is listed on the Nasdaq exchange.
What is Novus Therapeutics Inc worth?
Novus Therapeutics Inc (NVUS) has a market capitalization of 20.97M null. This makes NVUS a Nano Cap stock.
What are the support and resistance levels for Novus Therapeutics Inc (NVUS) stock?
Novus Therapeutics Inc (NVUS) has a support level at 14.27 and a resistance level at 15.31. Check the full technical report for a detailed analysis of NVUS support and resistance levels.
Should I buy Novus Therapeutics Inc (NVUS) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of NVUS, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of NVUS, evaluating the profitability, health, valuation and growth aspects
- Novus Therapeutics Inc (NVUS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Novus Therapeutics Inc (NVUS) Sales and EPS estimates to see what analysts future expectations are.
- Novus Therapeutics Inc (NVUS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Novus Therapeutics Inc (NVUS) Insider and Institutional Ownership to learn about the owners and their transactions.
- Novus Therapeutics Inc (NVUS) Stock Chart to make your own analysis
- Novus Therapeutics Inc (NVUS) Latest news and press-releases to stay up to date.
Does Novus Therapeutics Inc (NVUS) stock pay dividends?
NVUS does not pay a dividend.
What is the Price/Earnings (PE) ratio of Novus Therapeutics Inc (NVUS)?
Novus Therapeutics Inc (NVUS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-18.3).
NVUS Technical Analysis
NVUS Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to NVUS. While NVUS has a great health rating, there are worries on its profitability.
NVUS Financial Highlights
Over the last trailing twelve months NVUS reported a non-GAAP Earnings per Share(EPS) of -18.299999999999997. The EPS decreased by -243.98% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -10.93% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |